About this trial
Evaluation of new supraglottic device SaCo VLMA for laparoscopic procedures under general anesthesia in comparison with other airway management methods including other supraglottic devices. The parameters noted will be: demographic data, time for placement of SGA counted from moment of grabbing device by operator to correct placement, subjective evaluation of ease of insertion of SGA in 5 step Borg scale, peak pressure, lung compliance, achieved tidal volume before creating pneumoperitoneum, after creating pneumoperitoneum, visualization of glottis on monitor of camera or fiberoptic scope.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing elective surgery under general anesthesia for laparoscopic surgery of predicting lasting no longer than about 1 hour.
Age >18 years.
ASA I-III.
Present ordinary airway
Disqualifiers
Not meeting the above criteria
Presenting 3 predictors of a difficult airway (Mallampatti class III or IV; thyromental distance <6 cm, sternomental distance <12.5 cm, distance between incisors <4.0 cm, bite test II or III, cervical mobility <90o).
Gestation
Allergy to any drug included in the protocol.
Trial design
Parallel
Treatments tested in this trial
SaCo VLM or SAD or ET for airway control for laparoscopy
DeviceEvaluation of the new SGAs for airway control in anesthetized patients for laparoscopy procedures
Treatment groups
Trial outcomes
Primary outcomes
effectiveness of use
success ratio of insertion of SGA or ET in % of success insertion
effectiveness of mechanical ventilation
adequate ventilation described as maintaining adequate minute ventilation with acceptable leak in Tidal Volume in ml
safety of mechanical ventilation
providing adequate ventilation parameters - peak pressure in mmHg
parameters of mechanical ventilation
measurement of lung compliance in ml/mmHg
Secondary outcomes
safety of use of SaCo VLM
complications ratio related to airway management in %
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: